Form D — Grace Therapeutics, Inc.
0001140361-25-005827 · filed Feb 25, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $30,000,203
- Reported amount sold
- $14,999,985
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Grace Therapeutics, Inc.
- CIK
- 1444192
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 103 CARNEGIE CENTER
PRINCETON, New Jersey 08540 - Phone
- 609-322-1602
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Prashant Kohli · DirectorPrinceton, New Jersey Find on LinkedIn ↗
-
Vimal Kavuru · DirectorPrinceton, New Jersey Find on LinkedIn ↗
-
Robert J. DelAversano · Executive OfficerPrinceton, New Jersey Find on LinkedIn ↗
-
A. Brian Davis · DirectorPrinceton, New Jersey Find on LinkedIn ↗
-
S. George Kottayil · DirectorPrinceton, New Jersey Find on LinkedIn ↗
-
Edward Neugeboren · DirectorPrinceton, New Jersey Find on LinkedIn ↗
-
Dr. R. Loch Macdonald · Executive OfficerPrinceton, New Jersey Find on LinkedIn ↗
-
Carrie D'Andrea · Executive OfficerPrinceton, New Jersey Find on LinkedIn ↗
-
Amresh Kumar · Executive OfficerPrinceton, New Jersey Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗